These roles are underscored by human HBV data which show higher CREM activity in HBV-specific CXCR6+ CD8 T cells in patients with active hepatitis and less CREM activity with increasing viral control and absence of liver damage. This evidence concerns the gene CD8A and hepatitis A virus infection.